Final Recommendation Statement: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer

June 28, 2022
7:11 pm

Final Recommendation Statement: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer

The U.S. Preventive Services Task Force released today a final recommendation statement on vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease (CVD) and cancer. For most vitamins and mineral supplements, more research is needed to make a recommendation for or against taking them to prevent CVD and cancer. The Task Force recommends against taking vitamin E and beta-carotene for this purpose. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. The final recommendation statement can also be found in the June 21 online issue of JAMA.

Population

Recommendation

Grade

Community-dwelling, nonpregnant adults

The USPSTF recommends against the use of beta-carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer.

Community-dwelling, nonpregnant adults

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.

Community-dwelling, nonpregnant adults

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single or paired nutrient supplements (other than beta-carotene and vitamin E) for the prevention of cardiovascular disease or cancer.

WHY THIS MATTERS

“We all want ways to prevent heart disease, stroke, and cancer, so the Task Force again reviewed the evidence on whether taking vitamins and minerals helps prevent these diseases,” says Task Force member John Wong, M.D. “Unfortunately, based on the existing evidence, the Task Force cannot recommend for or against the use of most vitamins and minerals and is calling for more research.”

WHERE WE ARE IN THE PROCESS

Draft

Research Plan

Final

Research Plan

Draft

Recommendation / Draft Evidence Review

Final Recommendation / Evidence Summary